Circulating PD-L1, HGF, and MUC-16 have been associated with poor survival in BTC and other cancers [20,21,22,23,24], but all previous studies on BTC included less than 250 patients and lacked independent validation cohorts. The gene discussed is HGF; the disease is cancer.